USE OF OREGOVOMAB AND BEVACIZUMAB, PACLITAXEL, CARBOPLATIN FOR TREATMENT OF BRCA-WILD… Application WO-2022187957-A1 World Intellectual Property Organisation (WIPO) 15 Sep 2022